Virupaksha Organics to set up unit at Orvakal Node; to invest ₹1,225 Cr, create 1500 jobs in Andhra
The project involves an investment of ₹1,225 crore and has the potential to create around 1,500 direct jobs, besides substantial indirect employment
By - Newsmeter Network
Representational Image
Amaravati : Andhra Pradesh government has allocated 100 acres of land to Virupaksha Organics Limited to set up a manufacturing facility for Active Pharmaceutical Ingredients (APIs) and organic chemicals at the IP Guttapadu Cluster in the Orvakal Node of Kurnool district.
The project involves an investment of ₹1,225 crore and has the potential to create around 1,500 direct jobs, besides substantial indirect employment across logistics, utilities, and ancillary services.
Strategic location driving pharma investments
Orvakal’s rapid rise as a pharmaceutical cluster is being driven by its proximity to Hyderabad, excellent road connectivity, availability of large, contiguous industrial land parcels, and plug-and-play infrastructure developed by the Andhra Pradesh Industrial Infrastructure Corporation (APIIC). These advantages are prompting pharmaceutical companies to expand capacities in Andhra Pradesh while remaining closely linked to Hyderabad’s established life sciences ecosystem.
Company background
Virupaksha Organics Limited is a research-driven pharmaceutical company engaged in the manufacture of APIs and intermediates for both regulated and semi-regulated global markets. The company is known for its strong capabilities in process chemistry, quality compliance, and export-oriented manufacturing, serving leading pharmaceutical players across geographies.
Besides Virupaksha Organics, Sigachi Industries Limited, headquartered in Hyderabad, is also expanding its footprint in Andhra Pradesh. A leading manufacturer of pharmaceutical excipients, particularly microcrystalline cellulose (MCC), with applications across pharmaceuticals, food, and nutraceuticals, the company has customers spanning India, Europe, the United States, and other international markets. Sigachi has steadily expanded its manufacturing base to meet rising global demand.
MoUs signed at CII Partnership Summit in November 2025
The expansion plans of Virupaksha Organics and Sigachi Industries were formalised through MoUs signed at the CII Partnership Summit, reflecting Andhra Pradesh’s proactive investment promotion efforts and its commitment to providing speed, certainty, and scale to investors.
With multiple pharmaceutical and allied manufacturing projects now converging at Orvakal, Kurnool district is fast emerging as a key pharmaceutical manufacturing destination in South India, reinforcing Andhra Pradesh’s position as a competitive, industry-friendly state for life sciences investments.
